Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats

被引:9
|
作者
Briet, Francoise [1 ,4 ,5 ]
Keith, Mary [2 ,4 ,5 ]
Leong-Poi, Howard [3 ,4 ,5 ]
Kadakia, Ankit [1 ,2 ]
Aba-Alkhail, Khalid [2 ]
Giliberto, John-Paul [2 ]
Stewart, Duncan [3 ,4 ,5 ,6 ]
Errett, Lee [2 ,4 ,5 ]
Mazer, C. David [1 ,4 ,5 ,6 ]
机构
[1] St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada
[2] St Michaels Hosp, Div Cardiovasc Surg, Toronto, ON M5B 1W8, Canada
[3] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada
[4] St Michaels Hosp, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada
[6] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
Carnitine; Coenzyme Q(10); Taurine; Cardioprotection; Myocardial infarction;
D O I
10.1016/j.numecd.2007.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: We evaluated the impact of triple nutrient supplementation (TNS: carnitine, taurine and coenzyme Q(10)) vs. carnitine atone (CARN) or placebo on survival, infarct size, cardiac function and metabolic gene expression using a model of myocardial infarction (MI) in rats. Methods and results: Male Wistar rats were randomized to three groups divided in two independent studies prior to ligation of the left anterior descending coronary artery (LAD): TNS vs. Placebo and TNS vs. CARN. Nutrient supplementation [L-carnitine (300 mg/day), coenzyme Q(10) (15 mg/kg body weight/day) and taurine (0.1 M)] was administered daily for four weeks prior to and for 10 days after MI. At that time, cardiac function and infarct size were measured. Metabolic gene (mRNA) expression in the peri-infarct tissue of left ventricle from TNS, placebo or corresponding time-control rats (TNS or placebo without LAD ligation) was measured 10 days after MI. When compared to placebo, TNS significantly improved survival (60% vs. 34%, p < 0.02), cardiac function, and reduced infarct size (30 +/- 7% vs. 42 +/- 9%, p < 0.001). Although CARN improved survival like TNS (45% vs. 50%, not significant), it did not reduce infarct size (32 +/- 14% vs. 19 +/- 10%, p < 0.05) or delay myocardial remodeling. In the placebo group, MI was associated with a significantly altered pattern of metabolic gene expression (glucose transporter 1, liver carnitine palmitoyl transferase 1, medium-chain acyl-CoA dehydrogenase; p < 0.01 for all three) in the left ventricle peri-infarct tissue. In contrast, gene expression was normalized in the group receiving TNS. Conclusions: Our results support the potential cardioprotective impact of TNS during myocardial ischemia. In contrast to carnitine supplementation atone, TNS improved survival as well as cardiac function, gene expression and delayed remodeling. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:691 / 699
页数:9
相关论文
共 50 条
  • [31] An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model
    Perea Gil, I.
    Prat-Vidal, C.
    Galvez-Monton, C.
    Roura, S.
    Llucia-Valldeperas, A.
    Soler-Botija, C.
    Diaz-Guemes, I.
    Crisostomo, V.
    Sanchez-Margallo, F. M.
    Bayes-Genis, A.
    CARDIOVASCULAR RESEARCH, 2016, 111 : S8 - S8
  • [32] An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model
    Gil, I. Perea
    Prat-Vidal, C.
    Galvez-Monton, C.
    Roura, S.
    Llucia-Valldeperas, A.
    Soler-Botija, C.
    Crisostomo, V.
    Diaz-Guemes, I.
    Sanchez-Margallo, F. M.
    Bayes-Genis, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 514 - 514
  • [33] Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction
    Wang, Jingfeng
    Zhou, Jingmin
    Ding, Xuefeng
    Zhu, Lingti
    Jiang, Kun
    Fu, Mingqiang
    Wang, Shijun
    Hu, Kai
    Ge, Junbo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (06): : 6596 - 6606
  • [34] Transplantation of bone marrow cell overexpressing FrzA reduces infarct size and improves cardiac function after myocardial infarction in mice
    Barandon, L
    Couffinhal, T
    Dufourcq, P
    Ezan, J
    Leroux, L
    Moreau, C
    Alzieu, P
    Allieres, C
    Costet, P
    CIRCULATION, 2003, 108 (17) : 247 - 247
  • [35] Prior exercise improves survival, infarct healing, and left ventricular function after myocardial infarction
    de Waard, Monique C.
    Duncker, Dirk J.
    JOURNAL OF APPLIED PHYSIOLOGY, 2009, 107 (03) : 928 - 936
  • [36] Fto deficiency reduces infarct size and improves heart function after acute myocardial infarction
    Wehmoller, Melanie
    Gorressen, Simone
    Semmler, Dominik
    Ruther, Ulrich
    FASEB JOURNAL, 2018, 32 (01):
  • [37] Targeting Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction
    Sedding, Daniel
    Buaersachs, Johann
    Preissner, Klaus T.
    CIRCULATION, 2017, 136
  • [38] Isosteviol improves cardiac function and promotes angiogenesis after myocardial infarction in rats
    Fei Liu
    Laisi Song
    Zhiqiang Lu
    Tingwei Sun
    Jingwen Lun
    Chengbin Zhou
    Xiouou Sun
    Wen Tan
    Haishan Zhao
    Cell and Tissue Research, 2022, 387 : 275 - 285
  • [39] Isosteviol improves cardiac function and promotes angiogenesis after myocardial infarction in rats
    Liu, Fei
    Song, Laisi
    Lu, Zhiqiang
    Sun, Tingwei
    Lun, Jingwen
    Zhou, Chengbin
    Sun, Xiouou
    Tan, Wen
    Zhao, Haishan
    CELL AND TISSUE RESEARCH, 2022, 387 (02) : 275 - 285
  • [40] Postconditioning to Reduce Infarct Size Following Acute Myocardial Infarction
    Lockie, Tim
    Webb, Ian
    Chiribiri, Amedeo
    Saha, Mrin
    Jansen, Christian
    Williams, Rupert
    Plain, Sven
    Perera, Divaka
    Redwood, Simon
    Marber, Michael
    CIRCULATION, 2009, 120 (18) : S1467 - S1468